MedPath

Study on the Application of Convenient Foot-control Exhaust Method in Endoscopic Thyroidectomy

Not Applicable
Conditions
Papillary Thyroid Carcinoma
Thyroidectomy
Endoscopy
Thyroid Cancer
Interventions
Device: direct exhaust
Device: used of the Pressure adjustable foot-control method
Registration Number
NCT03411187
Lead Sponsor
Bo Wang,MD
Brief Summary

Endoscopic thyroidectomy developed rapidly in recent years, and the most popular surgical approach was endoscopic thyroidectomy by bilateral areola approach, but some operative steps was required optimization. One of the most annoying problem was the smog blurring endoscopic lens during surgery. The researcher summarized a set of convenient foot-control exhaust method and carried out this prospective study.

Detailed Description

The patients with papillary thyroid microcarcinoma were included according to the inclusive criteria and randomly divided them into two groups (foot-control exhaust group and direct exhaust group). The foot-control exhaust group used the foot-control exhaust method by the way of adjustable Pressure to intermittent exhaust, while direct exhaust group exhaust through the Trocar hole. Comparison of operation time, times of wiping the endoscopic lens, volume of postoperative drainage, and number of identified parathyroid gland between two groups.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Patients with maximum tumor diameter ≤1 cm;
  2. patients without lateral neck lymph node metastases;
  3. patients without distant metastases;
  4. patients who only needed unilateral surgery following the guidelines;
  5. patients with strong cosmetic requirement.

Exclusion criteria:

  1. Patients with maximum tumor diameter >1 cm;
  2. patients who needed complement total thyroidectomy according to the guidelines, including tumor extrathyroidal extension as well as large amount of neck lymph node metastases and distant metastases;
  3. patients without cosmetic requirements.
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
direct exhaust groupdirect exhaustdirect exhaust group exhaust through the Trocar hole.and without use of the Pressure adjustable foot-control method
foot-control exhaust groupused of the Pressure adjustable foot-control methodThe foot-control exhaust group used of the Pressure adjustable foot-control method by the way of adjustable Pressure to intermittent exhaust
Primary Outcome Measures
NameTimeMethod
Flap separation time1 day after surgery

Flap separation time was acquired from endoscopic video was the period from endoscopy into the body to building up operation space.

Central lymph node dissection time1 day after surgery

Central lymph node dissection time: was from separating central lymph node to the specimen removed.

Glandular excision time1 day after surgery

Glandular excision time was defined from incising cervical white line to removing Berry ligament.

Secondary Outcome Measures
NameTimeMethod
The number of identifying parathyroid glands1 day after surgery

The number of identifying parathyroid glands was evaluated at postoperation while parathyroid glands was identified during surgery.

Blood PTH levelpreoperative, first day after operation, one week after surgery, two months after surgery.

measurement of PTH level in blood

Blood calcium levelbefore surgery, the first day after surgery, one week after surgery, two months after surgery.

to measure the blood calcium level in the blood

Times of wiping lens1 day after surgery

Times of wiping lens calculated from endoscopic video after operation was defined the times of wiping lens from endoscopy into the body to central lymph node removed.

Volume of Postoperative drainage1 day,2 day,3 day after surgery

Volume of Postoperative drainage was accurately calculated the total volume while the drainage tube removed after operation.

Volume of intraoperative blood loss1 day after surgery

Volume of intraoperative blood loss was estimated the volume of intraoperative blood loss.

Trial Locations

Locations (1)

Wen-xin ZHAO

🇨🇳

Fuzhou, Fujian, China

© Copyright 2025. All Rights Reserved by MedPath